Ocular Surface Adverse Events are not Associated with Dupilumab use in Nasal Polyp Treatment. Swisher AR, Kshirsagar RS, Vu PQ, Liang J, et al. Laryngoscope 2024;134:2602-2608.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Swisher AR, Kshirsagar RS, Vu PQ, Liang J, et al. Ocular Surface Adverse Events are not Associated with Dupilumab use in Nasal Polyp Treatment. Laryngoscope 2024;134:2602-2608.
PMID: 38038233